Status:

WITHDRAWN

Postoperative Ibuprofen Use and Risk of Bleeding in Pediatric Tonsillectomy

Lead Sponsor:

Massachusetts Eye and Ear Infirmary

Collaborating Sponsors:

Emory University

University Hospitals Cleveland Medical Center

Conditions:

Tonsillectomy With or Without Adenoidectomy

Eligibility:

All Genders

2-18 years

Phase:

PHASE1

Brief Summary

Pediatric tonsillectomy is one of the most common surgical procedures annually in the United States; risks include postoperative hemorrhage and poor pain control. Controversy exists regarding optimal ...

Detailed Description

Pediatric tonsillectomy is one of the most common surgical procedures in the United States, with over 500,000 procedures performed annually.1,2 The most common indications for tonsillectomy with and w...

Eligibility Criteria

Inclusion

  • Male and female patients ages 2-18 undergoing tonsillectomy with or without adenoidectomy by electrocautery alone for all indications
  • Patients with complex medical conditions and craniofacial abnormalities will be included.
  • Family must understand and be able to read English.
  • Only patients who are not pregnant will be included.
  • Informed consent and, child assent (when appropriate) will be required for enrollment. Patients will provide signed and dated informed consent form.
  • Subjects will be willing and able to comply with all study procedures and be available for the duration of the study.

Exclusion

  • Patients with a known personal or family history of a bleeding disorder.
  • Patients with a history of asthma, kidney or liver problems.
  • Patients with tonsillectomy or adenoidectomy performed using a cold knife technique, microdebrider, coblation or plasma knife.
  • Patients on NSAIDs for other medical conditions or those who have taken NSAIDs within 1 week of surgery
  • Patients with allergy to aspirin or other NSAIDs, acetaminophen, Red Dye #40 or Red Dye #33
  • Patients found to be pregnant will be excluded from participation. Pregnancy testing using urine beta-HCG will be performed on all children \> 13 years of age, or those younger than 13 who are menstruating; this is the testing protocol used at the Children's Hospital of Boston.
  • Patients unwilling to enroll in the study will have the tonsillectomy with or without adenoidectomy performed according to current practice standards.

Key Trial Info

Start Date :

September 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03385057

Start Date

September 1 2018

End Date

January 1 2023

Last Update

September 20 2018

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Rady's Children's Hospital

San Diego, California, United States, 92123

2

Emory University and Children's Healthcare of Atlanta

Atlanta, Georgia, United States, 30322

3

Case Western University- Raimbow Babies and Children's

Cleveland, Ohio, United States, 44106

4

Portsmouth Naval Hospital

Portsmouth, Virginia, United States, 23708-2197